TY  - CHAP
AU  - Jue Wang
AU  - Brent B. Freeman
AU  - Paul Mathew
ED  - Ravinder Mohan
Y1  - 2016-09-28
PY  - 2016
T1  - The Emerging Role of PARP Inhibitors in the Treatment of Prostate Cancer
N2  - Prostate cancer is diagnosed commonly in the course of general health screening. Very often it is difficult to tell whether the cancer will be aggressive and lethal or will be so slow growing that it will not affect the patient's survival. Treatment can have a major impact on the patient's health-related quality of life. This book presents cutting-edge research in predicting the behavior of localized and metastatic cancer, targeted treatment of cancer that has spread minimally, response to newer methods of treatment, and rehabilitation of patients.
BT  - Prostate Cancer
SP  - Ch. 13
UR  - https://doi.org/10.5772/63283
DO  - 10.5772/63283
SN  - 978-953-51-2645-4
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-27
ER  -